LivaNova PLC (LIVN)

Market Cap	2.48B
Revenue (ttm)	1.28B
Net Income (ttm)	-222.15M
Shares Out	54.53M
EPS (ttm)	-4.09
PE Ratio	n/a
Forward PE	12.40
Dividend	n/a
Ex-Dividend Date	n/a

Volume	409,159
Open	45.86
Previous Close	45.76
Day's Range	45.30 - 46.38
52-Week Range	32.48 - 57.35
Beta	0.90
Analysts	Strong Buy
Price Target	59.29 (+30.31%)
Earnings Date	Jul 30, 2025

About LIVN

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connect...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 10, 1993
• Employees: 2,900
• Stock Exchange: NASDAQ
• Ticker Symbol: LIVN
• Website: https://www.livanova.com

Financial Performance

In 2024, LivaNova's revenue was $1.25 billion, an increase of 8.66% compared to the previous year's $1.15 billion. Earnings were $63.23 million, an increase of 260.39%.

Analyst Forecast

According to 7 analysts, the average rating for LIVN stock is "Strong Buy." The 12-month stock price forecast is $59.29, which is an increase of 30.31% from the latest price.

Price Target

$59.29

(30.31% upside)

Analyst Consensus: Strong Buy